Zobrazeno 1 - 10
of 297
pro vyhledávání: '"G, van der Pluijm"'
Autor:
A.F. Van De Merbel, G. Van Der Horst, M.H. Van Der Mark, D.J.M. Van Den Wollenberg, A.N. Pronk-Van Montfoort, R.C. Hoeben, G. Van Der Pluijm
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e1837- (2020)
Externí odkaz:
https://doaj.org/article/2f8b6a70f27143e1902ea68f8c3ef0b3
Autor:
G. van der Pluijm, N.J. Maitland, B.E. Snaar-Jagalska, T. Visakorpi, A.T. Collins, R.C.M. Pelger, J.K. Rane, L. Chen, A.F. van de Merbel, G. van der Horst, E. Zoni
Supplementary Figure Legend. Legend for Supplementary Figures S1-S2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b5c0566741b428256e8024a56c001f
https://doi.org/10.1158/0008-5472.22405448.v1
https://doi.org/10.1158/0008-5472.22405448.v1
Autor:
G. van der Pluijm, N.J. Maitland, B.E. Snaar-Jagalska, T. Visakorpi, A.T. Collins, R.C.M. Pelger, J.K. Rane, L. Chen, A.F. van de Merbel, G. van der Horst, E. Zoni
Supplementary Tables S1-S2. Real time-qPCR primers (S1); Primers used for cloning and mutagenesis (S2).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139fcc9e585a7d628e4792027b84a572
https://doi.org/10.1158/0008-5472.22405439.v1
https://doi.org/10.1158/0008-5472.22405439.v1
Autor:
G. van der Pluijm, N.J. Maitland, B.E. Snaar-Jagalska, T. Visakorpi, A.T. Collins, R.C.M. Pelger, J.K. Rane, L. Chen, A.F. van de Merbel, G. van der Horst, E. Zoni
Supplementary Figure S2. miR-25 strongly changes cell morphology without affecting proliferation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56df1e35567c3183cdad86aa0bd5c323
https://doi.org/10.1158/0008-5472.22405442
https://doi.org/10.1158/0008-5472.22405442
Autor:
A.F. Van De Merbel, G. van der Pluijm, D.J.M. Van Den Wollenberg, M.H. Van Der Mark, Tilly Aalders, T.J.A. Janssen, Christianne Groeneveldt, Jack A. Schalken, Nadine A.G. Pronk-van Montfoort, Rob C. Hoeben, G. Van Der Horst, Niven Mehra, Selas T F Bots
Publikováno v:
European Urology Open Science. 32:S175
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c3e99a0d42efe9e1954fe69c3bc67bf
https://doi.org/10.1016/s2666-1683(21)01195-2
https://doi.org/10.1016/s2666-1683(21)01195-2
Autor:
G. Van Der Horst, A.F. Van De Merbel, M.H. Van Der Mark, T.J.A. Janssen, L.C.M. Hensen, D.J.M. Van Den Wollenberg, R.C. Hoeben, R.F.M. Bevers, R.C.M. Pelger, G. Van Der Pluijm
Publikováno v:
European Urology Open Science. 32:S181
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f98d2d04d5e98877ad0972861be80b33
https://doi.org/10.1016/s2666-1683(21)01201-5
https://doi.org/10.1016/s2666-1683(21)01201-5
Autor:
S.E. Le Devedec, J. Crooijmans, Henri H. Versteeg, E.H. Laghman, Jeroen T. Buijs, Esther M. Vletter, R.F.P. van den Akker, C. Tieken, G. van der Pluijm, K. van der Molen, Chantal Kroone
It has been well-established that cancer results in a hypercoagulable state and an increased risk for venous thromboembolism (VTE). More recently, it has been suggested that coagulation may also affect cancer progression and metastasis. Cancer patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf9f2b7a04c65dacfde7dabe17aeb61
https://doi.org/10.1016/j.thromres.2018.02.091
https://doi.org/10.1016/j.thromres.2018.02.091
Autor:
Rob C.M. Pelger, Joost L. Boormans, Janneke van Uhm, G. Van Der Horst, Chris H. Bangma, M.H. Van Der Mark, M. Kruithof-De Julio, E.C. Zwarthoff, A.F. Van De Merbel, G. van der Pluijm, Emily Ploeg, Marja Jäätelä, Eline Ruigrok
Publikováno v:
European Urology Supplements. 18:e1637
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb49e460a0c9dfb88f0380e657ddf9e3
https://doi.org/10.1016/s1569-9056(19)31189-3
https://doi.org/10.1016/s1569-9056(19)31189-3
Autor:
L, Chen, A, Groenewoud, C, Tulotta, E, Zoni, M, Kruithof-de Julio, G, van der Horst, G, van der Pluijm, B, Ewa Snaar-Jagalska
Publikováno v:
Methods in cell biology. 138
Lethal and incurable bone metastasis is one of the main causes of death in multiple types of cancer. A small subpopulation of cancer stem/progenitor-like cells (CSCs), also known as tumor-initiating cells from heterogenetic cancer is considered to me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7d81f45b64d786189dc8b0a514ed91b
https://pubmed.ncbi.nlm.nih.gov/28129855
https://pubmed.ncbi.nlm.nih.gov/28129855
Autor:
Peter Kloen, Sofia Karkampouna, Rob C.M. Pelger, G J L H van Leenders, Lijkele Beimers, Zoraide Granchi, E Snaar-Jagalska, F. La Manna, Lanpeng Chen, M D Henry, Eugenio Zoni, Esther I. Verhoef, Peter C. Gray, M. Kruithof-De Julio, G. van der Pluijm, Jonathan A. Kelber
Publikováno v:
Oncogene, 36(33), 4739-4749. Nature Publishing Group
Oncogene
Oncogene, 36(33), 4739-4749. NATURE PUBLISHING GROUP
Oncogene, 36, 4739-4749
Oncogene
Oncogene, 36(33), 4739-4749. NATURE PUBLISHING GROUP
Oncogene, 36, 4739-4749
CRIPTO (CR-1, TDGF1) is a cell surface/secreted oncoprotein actively involved in development and cancer. Here, we report that high expression of CRIPTO correlates with poor survival in stratified risk groups of prostate cancer (PCa) patients. CRIPTO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4645ffd2a127d7055b2afd3b45146b
https://hdl.handle.net/1887/57644
https://hdl.handle.net/1887/57644